Quantification of fexofenadine in biological matrices: a review of bioanalytical methods

Biomedical Chromatography : BMC
Ming Yao, Nuggehally R Srinivas

Abstract

Fexofenadine (FEX) has been extensively used for therapeutic benefits after the market withdrawal of terfenadine. Recently, the popularity of FEX has emerged owing to its unique disposition via drug transporters and, hence, it has been used as a model probe for both in vitro and in vivo investigations to understand mechanistic aspects of drug-drug interactions (DDI). Going hand in hand with the increased use of FEX in therapy and research, numerous bioanalytical methods for FEX have been published. The various published bioanalytical methods for FEX are collated in this review to provide a comprehensive information on extraction methodology, assay conditions, chromatography and detection systems. Generally, the published methods have been adequately validated and can be readily used to support the use of FEX in pharmcokinetic, DDI and mechanistic investigations.

References

Mar 10, 2001·Clinical Pharmacology and Therapeutics·M A HammanS D Hall
Feb 5, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ute HofmannMartin F Fromm
Jun 28, 2002·Clinical Pharmacology and Therapeutics·Zaiqi WangStephen D Hall
Jun 15, 2004·Journal of Pharmaceutical and Biomedical Analysis·Tsukasa UnoTomonori Tateishi
Jul 15, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Maki ShimizuYuichi Sugiyama
May 13, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ryan Z TurncliffKim L R Brouwer
Aug 29, 2006·Journal of Pharmaceutical and Biomedical Analysis·Masatomo MiuraToshio Suzuki
Jan 19, 2007·Chirality·Masatomo MiuraToshio Suzuki
Sep 7, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Naoe YamaneYuji Kumagai
Feb 5, 2008·Molecular Pharmacology·Soichiro MatsushimaYuichi Sugiyama
Feb 26, 2008·British Journal of Clinical Pharmacology·Tomonori TateishiTsukasa Uno
Sep 24, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Agnès PoirierChristoph Funk
Jun 26, 2009·British Journal of Clinical Pharmacology·Takashi SakugawaTsukasa Uno
Dec 2, 2009·Expert Opinion on Drug Metabolism & Toxicology·Masatomo Miura, Tsukasa Uno
Jan 5, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Melonie L StantonReginald F Frye
Feb 13, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yeamin HuhDae-Duk Kim
Mar 24, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Graham LappinColin Garner
Mar 26, 2010·Indian Journal of Pharmaceutical Sciences·D NagendrakumarM V Rampure
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·A YamazakiM Maeda
Sep 15, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jingwei ZhangGuangji Wang
Sep 16, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yumiko AkamineTsukasa Uno
Feb 12, 2011·Journal of Pharmaceutical and Biomedical Analysis·Yohei SakaguchiHitoshi Nohta
Jun 16, 2011·British Journal of Clinical Pharmacology·Chaitali PasseyPamala A Jacobson
Jul 19, 2011·Rapid Communications in Mass Spectrometry : RCM·Colleen A FlynnGregory A Reed
Oct 4, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Makoto KataokaShinji Yamashita

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.